ArticleClinical kidney journal2025
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidence.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The epidemiology of end-stage kidney failure in France: reason for hope?Clinical kidney journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite France's universal healthcare system, significant geographic disparities in the incidence of end-stage kidney disease (ESKD) persist. We hypothesized that social deprivation is a major driver of these spatial variations, independent of healthcare access and clinical risk factors, and that its contribution is stable over time. Methods: We conducted an ecological study including 102 226 incident ESKD cases across 34 830 municipalities in metropolitan France from 2012 to 2021, using data from the national REIN (Renal Epidemiology and Information Network) registry. A Bayesian hierarchical spatiotemporal model was used to estimate the association between ESKD incidence and ecological-level covariates: social deprivation [measured by the French European Deprivation Index (EDI)], diabetes prevalence, dialysis center accessibility and long-term exposure to PM Results: Social deprivation was strongly associated with ESKD incidence [relative risk per 1 standard deviation increase in EDI: 1.10 (95% credible interval 1.09-1.11)] and explained 34.7% of its spatial variability. The association was only partially mediated by diabetes prevalence [mediation proportion: 15.3% (95% confidence interval 12.5-18.2)]. The model incorporating all covariates explained 49.9% of the observed spatial heterogeneity. The effect of social deprivation remained consistent over time. Reducing deprivation in the most disadvantaged areas to the levels of the 5th, 25th and 50th percentiles of less deprived areas could have prevented an estimated 23 092, 17 450 and 13 601 ESKD cases, respectively, over the study period. Conclusions: Social deprivation is the leading ecological determinant of spatial disparities in ESKD incidence in France, with limited mediation by clinical factors and persistent effects despite universal healthcare. These findings underscore the need to address social determinants of health and to adapt kidney care delivery models to better reach socioeconomically disadvantaged populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.